Search

Search Constraints

You searched for: Author/Creator Amaria, Rodabe

Search Results

1. 311 Phase II trial of lymphodepletion plus adoptive cell transfer with or without dendritic cell vaccination in patients with metastatic melanoma. (10th December 2020)

2. 311 Phase II trial of lymphodepletion plus adoptive cell transfer with or without dendritic cell vaccination in patients with metastatic melanoma. (9th November 2020)

3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

4. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

5. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

6. Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. (December 2018)

7. Correction to: Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis. Issue 1 (17th April 2019)

8. Erythema nodosum‐like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy—Report of 2 patients. (13th October 2017)

9. Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis. Issue 1 (11th October 2018)

10. Melanoma and immunotherapy bridge 2015. Issue 1 (July 2016)